ResMed Inc.
Cash Flow Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $315.6M | $342.3M | $352.4M | $352.9M | $345.3M | $307.1M | $254.9M | $227.0M |
| Depreciation & Amortization | $120.0M | $112.2M | $86.8M | $73.1M | $73.5M | $78.3M | $85.9M | $70.6M |
| Depreciation | $64.7M | — | — | — | — | — | — | — |
| Amortization | $27.3M | $46.6M | $30.2M | $15.0M | $15.9M | $17.0M | $14.0M | $10.1M |
| Stock-Based Compensation | $48.4M | $45.9M | $46.4M | $47.9M | $43.5M | $38.2M | $30.6M | $30.8M |
| Net Cash from Operating Activities | $505.0M | $414.1M | $547.9M | $383.2M | $391.3M | $402.8M | $383.2M | $283.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $62.6M | $62.2M | $58.5M | $62.5M | $72.7M | $63.6M | $47.1M | $66.6M |
| Business Acquisitions | $902.0K | $7.3M | $1.04B | $29.4M | $3.9M | $5.4M | $53.3M | $22.5M |
| Net Cash from Investing Activities | $-101.8M | $-81.9M | $-1.13B | — | — | $-78.0M | $-101.6M | $-76.5M |
| Financing Activities | ||||||||
| Dividends Paid | $199.5M | $186.3M | $168.1M | $157.3M | $141.5M | $97.2M | — | — |
| Stock Repurchases | $53.8M | — | $102.1M | $160.3M | $202.2M | $186.3M | $392.7M | $163.3M |
| Net Cash from Financing Activities | $-1.03B | $-262.9M | $612.6M | — | — | $-153.9M | $-177.1M | $-79.3M |
| Net Change in Cash | $-633.2M | $90.5M | $14.2M | $-188.5M | $29.7M | $66.5M | $74.3M | $246.5M |
| Free Cash Flow | $442.4M | $351.8M | $489.4M | $320.7M | $318.5M | $339.2M | $336.0M | $216.6M |